Craneware PLC primarily operates in the healthcare industry.

The main competitors of Craneware PLC in the market include healthcare technology companies such as Cerner Corporation, Allscripts Healthcare Solutions, and Epic Systems Corporation.

Craneware PLC is a leading healthcare software company based in Edinburgh, Scotland. Founded in 1999, Craneware specializes in developing innovative solutions to help hospitals and healthcare organizations optimize financial performance and improve patient outcomes. Over the years, the company has established a strong reputation for its market-leading revenue integrity and cost management solutions. With a customer base spanning the United States, the United Kingdom, and other international markets, Craneware continues to grow and expand its presence in the healthcare industry. The company's commitment to delivering exceptional results and its focus on driving value for its customers have made Craneware an industry leader in healthcare software solutions.

Craneware PLC, a leading software company, has achieved numerous significant milestones throughout its history. The company has successfully expanded its global presence, establishing a strong client base across the United States and other international markets. Craneware PLC has consistently delivered innovative software solutions tailored to the specific needs of the healthcare industry, enabling healthcare organizations to optimize their financial performance. The company has also received prestigious accolades, including recognition as one of the UK's fastest-growing technology companies. Craneware PLC's commitment to continuous growth and driving positive change in the healthcare sector has positioned it as a trusted and reliable partner for organizations seeking financial excellence and operational efficiency.

Craneware PLC primarily operates in the United States and the United Kingdom.

Craneware PLC represents a strong commitment to ethical business practices and transparency. The company's corporate philosophy revolves around delivering value to its customers by providing innovative revenue integrity solutions for the healthcare industry. Craneware PLC values integrity, accountability, and customer success, ensuring that its products and services meet the evolving needs of healthcare providers. With a focus on driving financial performance and optimizing revenue, Craneware PLC offers sophisticated software solutions that empower healthcare organizations to enhance their operational efficiency and improve financial outcomes. By prioritizing customer satisfaction and promoting a culture of excellence, Craneware PLC continues to be a trusted and respected name in the healthcare software industry.

Analysts currently set an average price target of 4,098.23 USD for the Craneware stock (median: 3,967.94 USD), implying +21,449.3 % versus the latest price. The consensus is based on 13 analyst ratings.

Craneware Analyst Price Targets 2026

13 analysts currently rate the Craneware stock: 12 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Craneware to generate revenue of 207.42 M USD and earnings per share of 1.13 USD.

Craneware Analyst Price Targets 2026

Converted at the current exchange rate, the Craneware share trades at 16.47 EUR (19.02 USD).

The Craneware share (CRW.L) is listed on 4 stock exchanges, including: Frankfurt (3X6.F), London (CRW.L), London (CRW.L).

Craneware PLC is an internationally operating company specializing in providing software solutions in the field of hospital administration. The company has been listed on the London Stock Exchange since 2007 and is headquartered in Edinburgh, Scotland. Craneware's business model is focused on helping hospitals optimize their processes and increase their revenues. Craneware offers a range of software products that contribute to maximizing cost efficiency and revenue by enabling better management of services, billing, and contracts. One of Craneware's key divisions is the provision of billing management software. This software assists hospitals in creating more accurate and faster billing, leading to increased efficiency and faster payment. The software can also help reduce billing errors and avoid fines. Another important area of Craneware is contract management. The company offers a software platform that allows hospitals to better manage their contracts with suppliers and insurance companies. This includes monitoring contract terms and providing reports on the performance of contract partners. Craneware also offers tools to support cost calculations. This software allows hospitals to more accurately forecast their costs and better plan their procurement and management budgets. In addition, Craneware offers training and consulting services to support hospitals and their staff in implementing the software and improving their processes. In addition to its extensive product range, Craneware is also committed to continuously improving and updating its software. The company invests significantly in research and development to ensure that its products meet the changing needs of customers and the industry. In 2019, Craneware generated revenue of £76.8 million. Most of the revenue was generated in the UK and the US, where the company has offices. Craneware has customers in more than 50 countries worldwide and is committed to expanding its presence in key growth markets. In summary, Craneware's business model is focused on providing innovative software solutions for hospital administration to improve cost efficiency and facility performance. The company's various divisions offer a wide range of products and services aimed at optimizing revenue factors and strategic options for hospitals and their staff.

The expected revenue of Craneware is 207.42 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Craneware is 40.08 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Craneware is currently 16.89. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Craneware stock.

The price-to-sales ratio (P/S) of Craneware is currently 3.26. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Craneware stock.

The Eulerpool Quality Score for Craneware is 7/10.

The ISIN of Craneware is GB00B2425G68. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Craneware is A0MS3H. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Craneware is CRW.L. The ticker symbol is used to trade Craneware shares on the stock exchange.

Over the past 12 months, Craneware paid a dividend of 0.32 USD . This corresponds to a dividend yield of about 1.68 %. For the coming 12 months, Craneware is expected to pay a dividend of 0.38 USD.

The current dividend yield of Craneware is 1.68 %.

Craneware pays a dividend, distributed in the months of , , , .

Craneware paid dividends every year for the past 18 years.

For the upcoming 12 months, dividends amounting to 0.38 USD are expected. This corresponds to a dividend yield of 1.99 %.

Craneware is assigned to the 'Health' sector.

To receive the latest dividend of Craneware from amounting to 0.19 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Craneware distributed 0.29 USD as dividends.

The dividends of Craneware are distributed in USD.